Study of Bencycloquidium Bromide Nasal Spray in the Treatment of Moderate-severe Persistent Allergic Rhinitis

NCT05038202 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis

Interventions

DRUG: Bencycloquidium Bromide Nasal Spray
DRUG: Mometasone Furoate Aqueous Nasal Spray

Sponsor

Yingu Pharmaceutical Co., Ltd